These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18625423)

  • 21. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kennedy disease: report of 2 cases].
    Seefeld M; Cunha FM; Ferraz LE; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):471-4. PubMed ID: 8540824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral palsy masking spinal muscular atrophy.
    Ocasio-Silva MA; McBride A; Moberg-Wolff E
    J Pediatr Rehabil Med; 2008; 1(2):179-83. PubMed ID: 21791763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation.
    Martínez-Hernández R; Soler-Botija C; Also E; Alias L; Caselles L; Gich I; Bernal S; Tizzano EF
    J Neuropathol Exp Neurol; 2009 May; 68(5):474-81. PubMed ID: 19525895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
    Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spinal muscular atrophy. A 4-year prospective, multicenter, longitudinal study (168 cases)].
    Barois A; Mayer M; Desguerre I; Chabrol B; Berard C; Cuisset JM; Leclair-Richard D; Visconti-Lougovoy J; Hatton F; Estournet-Mathiaud B
    Bull Acad Natl Med; 2005 Jun; 189(6):1181-98; discussion 1198-9. PubMed ID: 16433443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kennedy's disease--case report].
    Tomczykiewicz K; Wrodycka B; Sułek A
    Pol Merkur Lekarski; 2005 Mar; 18(105):307-9. PubMed ID: 15997639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease.
    Jedrzejowska M; Milewski M; Zimowski J; Borkowska J; Kostera-Pruszczyk A; Sielska D; Jurek M; Hausmanowa-Petrusewicz I
    Acta Biochim Pol; 2009; 56(1):103-8. PubMed ID: 19287802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
    Lunke S; El-Osta A
    J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gene diagnosis for spinal muscular atrophy and its application study].
    Cao DH; Ren MH; Lin CK; Cui WT; Ma HW; Wu YY; Jin CL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):306-9. PubMed ID: 19504445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials in spinal muscular atrophy.
    Kaufmann P; Iannaccone ST
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):653-60, xii. PubMed ID: 18625422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
    Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
    Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity and Reliability of the Neuromuscular Gross Motor Outcome.
    Alfano LN; Iammarino MA; Reash NF; Powers BR; Shannon K; Connolly AM; Waldrop MA; Noritz GH; Shell R; Tsao CY; Flanigan KM; Mendell JR; Lowes LP
    Pediatr Neurol; 2021 Sep; 122():21-26. PubMed ID: 34271497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case series: anesthetic management of patients with spinal and bulbar muscular atrophy (Kennedy's disease).
    Niesen AD; Sprung J; Prakash YS; Watson JC; Weingarten TN
    Can J Anaesth; 2009 Feb; 56(2):136-41. PubMed ID: 19247761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spinal muscular atrophy in the ENT area].
    García de Hombre AM; Balderrama Caballero DH
    Acta Otorrinolaringol Esp; 2007 Oct; 58(8):378-80. PubMed ID: 17949668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anesthetic management of a patient with progressive spinal muscular atrophy].
    Shime N; Hosokawa T; Hori Y; Hashimoto T; Miyazaki M
    Masui; 1990 Jul; 39(7):918-20. PubMed ID: 2214127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing therapeutic landscape of spinal muscular atrophy.
    Davidson JE; Farrar MA
    Aust J Gen Pract; 2022; 51(1-2):38-42. PubMed ID: 35098272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcomes in women with spinal muscular atrophy: A review.
    Abati E; Corti S
    J Neurol Sci; 2018 May; 388():50-60. PubMed ID: 29627031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy.
    Nguyen thi Man ; Humphrey E; Lam LT; Fuller HR; Lynch TA; Sewry CA; Goodwin PR; Mackenzie AE; Morris GE
    Neurology; 2008 Nov; 71(22):1757-63. PubMed ID: 18633133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
    Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
    Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.